Underpowered studies resulting from insufficient recruitment is one of the most common causes of clinical trial and research failure. Digital clinical trial and research (DCTR) platforms alleviate the challenges of traditional recruitment and consent procedures.
Target recruitment more precisely.
Flexible participant-facing electronic eligibility assessments make it easier to screen large populations for participants who meet complex criteria with less effort by each potential participant.
Digital recruitment methods can reach patients anywhere, thus expanding the potential pool of participants, including historically underrepresented populations.
Increase participant comprehension.
DCTR platforms enable use of multimedia (e.g., videos, voiceovers, images) to deliver informed consent content, which can improve participant comprehension of the study and subsequently increase retention. Comprehension quizzes can also be utilized to ensure all individuals are properly educated on the consent.
Improve participant experience.
Participants are able to complete eConsent on their own time, in the comfort of their home, and at their own pace.
DCTR platforms facilitate version control and “gatekeeping.” This can ensure participants see the most current version of consent materials and complete study steps in the correct order, as subsequent steps are not made available until eConsent is completed.